• SENSEX 80,346.88
    58.50 (+0.07%)
  • BANKNIFTY 55,391.25
    -41.55 (--0.07%)
  • Mazagon Dock
    3,149.70 3,047.00(%)
  • Reliance Industr
    1,411.85 1,608.95(%)
  • Garden Reach Sh.
    1,855.00 890.05(%)
  • Bajaj Finance
    8,560.00 6,376.55(%)
  • Cochin Shipyard
    1,600.40 1,169.00(%)
  • Torrent Pharma.
    3,360.00 3,589.95(%)
  • Tata Motors
    641.10 542.55(%)
  • Hind.Aeronautics
    4,466.00 3,045.95(%)
  • Paras Defence
    1,469.00 1,592.75(%)
  • Samvardh. Mothe.
    131.75 107.30(%)
  • Data Pattern
    2,459.05 1,350.50(%)
  • IndusInd Bank
    810.40 605.40(%)
  • Varun Beverages
    507.45 419.40(%)
  • Bharat Electron
    312.50 221.00(%)
  • Trent
    5,134.00 4,058.45(%)
  • Hitachi Energy
    14,879.00 16,534.50(%)
  • Sonata Software
    417.90 762.00(%)
  • ICICI Bank
    1,424.00 1,051.50(%)
  • Tech Mahindra
    1,510.60 1,807.40(%)
  • HDFC Bank
    1,936.40 1,977.95(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Pfizer Ltd Pharmaceuticals - Multinational

  • MNC Associate
  • BSE Code : 434.0
  • ISIN : INE182A01018
4,268.40 -6 (-0.13%)
  • As on 30 Apr 2025 (EOD)
  • Today’s Low

    4,211.00
  • Today’s High

    4,297.80
  • Open

    4,295.50
  • Perv Close

    4,274.10
  • 52W Low

    3,701.00
  • 52W High

    6,451.15

Key Indicators

  • P/E(TTM)

    31.66

  • Mar.Cap (₹Cr.)

    19,526.96

  • Div & Yield %

    0.82

  • Book Value(₹)

    819.90

  • Debt-Equity Ratio

    -0.13

  • AGM Date

    29-Apr-2025

  • EPS

    134.55

  • P/E Ratio

    31.66

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    19,526.96

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    45.75

  • BV (₹)

    819.90

  • Sales( ₹ in Cr.)

    2,193.17

  • NP (in Cr.)

    547.71

  • NP Var(%)

    -9.0

  • Div%

    350.0

  • CPS (₹)

    133.30

  • EPS (₹)

    119.70

  • Traded Value (₹ in Lakhs)

    19,486.02

  • 52 Week High

    6,451.15

  • 52 Week Low

    3,701.00

  • Price BSE

    4259.0

  • Price NSE

    4,268.00

  • Market Capital( in Cr.)

    19,486.02

  • P/C Ratio

    31.90

  • P/E Ratio

    35.60

  • Price Vs.BV

    119.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 2,193.17 2,424.76 2,610.99 2,238.55 2,151.65 2,081.50
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 2,193.17 2,424.76 2,610.99 2,238.55 2,151.65 2,081.50
Other Income 188.46 134.05 62.65 81.12 184.02 167.39
Stock Adjustments 11.82 -56.48 72.90 -14.35 36.62 90.88
Total Income 2,393.45 2,502.33 2,746.54 2,305.32 2,372.29 2,339.77
EXPENDITURE :            
Raw Materials 804.39 817.19 1,020.93 783.39 829.02 838.78
Power and Fuel Cost 3.98 6.51 5.67 5.79 11.04 11.45
Employee Cost 347.80 331.68 403.67 361.06 364.51 323.84
Other Manufacturing Expenses 51.17 51.63 59.81 60.26 54.26 62.54
Selling and Administration Expenses 317.96 298.03 310.77 268.67 319.66 335.32
Miscellaneous Expenses 44.37 54.29 47.10 32.63 37.06 34.82
Employee Benefit Expenses 347.80 331.68 403.67 361.06 364.51 323.84
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,569.67 1,559.33 1,847.95 1,511.80 1,615.55 1,606.75
Operating Profit 823.78 943.00 898.59 793.52 756.74 733.02
Interest 15.43 13.48 10.70 15.39 11.01 1.72
Gross Profit 808.35 929.52 887.89 778.13 745.73 731.30
Depreciation 62.28 105.51 115.00 109.41 103.24 71.39
Profit Before Tax 746.07 824.01 772.89 668.72 642.49 659.91
Current Tax 158.63 251.99 196.26 183.63 133.20 243.77
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 36.11 -51.91 -35.93 -12.52 0.16 -12.91
Reported Net Profit 551.33 623.93 612.56 497.61 509.13 429.05
Extraordinary Items 3.62 22.95 1.13 0.06 -0.80 0.01
Adjusted Net Profit 547.71 600.98 611.43 497.55 509.93 429.04
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 1,460.05 1,133.47 681.03 1,693.08 1,308.04 989.29
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 182.99 297.35 160.12 1,509.66 124.09 110.30
P & L Balance carried down 1,828.39 1,460.05 1,133.47 681.03 1,693.08 1,308.04
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 350.00 700.00 350.00 350.00 3,300.00 225.00
Dividend Per Share(Rs) 35.00 70.00 35.00 35.00 330.00 22.50
Earnings Per Share-Unit Curr 120.51 136.38 133.89 108.77 111.29 93.78
Earnings Per Share(Adj)-Unit Curr 120.51 136.38 133.89 108.77 111.29 93.78
Book Value 785.91 701.05 626.10 523.07 742.18 658.22
Book Value(Adj)-Unit Curr 785.91 701.05 626.10 523.07 742.18 658.22

Shareholding Pattern

  • Promoter Group

    63.92%

  • Public Share Holding

    36.08%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 29,243,042 63.92 29,243,042 7
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 29,243,042 63.92 29,243,042 7
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 0 0.00 0 0
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 188 0.00 125 4
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 6,972 0.02 5,973 18
Foreign Bank 186 0.00 0 1
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 998,266 2.18 998,255 65
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 2,482,140 5.43 2,482,140 10
Mutual Funds / UTI 5,303,621 11.59 5,303,121 24
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 30,173 0.07 30,173 7
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 8,821,546 19.28 8,819,787 129
2] Non Institution
Bodies Corporate 1,222,132 2.67 1,217,550 596
Clearing Members 2,373 0.01 2,371 9
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 243,749 0.53 242,808 2,974
Foreign Non Institution Other 310 0.00 0 2
Hindu Undivided Families 144,251 0.32 144,251 2,164
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 212,408 0.46 212,408 7
Individuals holding nominal share capital up to Rs. 1 lakh 5,433,426 11.88 5,140,517 102,362
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 2,240 0.00 2,205 9
Others 422,255 0.92 422,255 2
Sub Total 7,683,144 16.79 7,384,365 108,125
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 45,747,732 100.00 45,447,194 108,261

Company Background

Pfizer LtdPharmaceuticals - Multinational

  • Pfizer Ltd
  • BSE Code : 434.0
  • ISIN : INE182A01018
  • Incorporation Year

    1950

  • Registered Office

    The Capital 1802/1901 Plot-C70
    G Bl Bandra Kurla Cpx Bandra-E, Mumbai,
    Maharashtra-400051

  • Telephone

    91-22-66932000

  • FAX

    91-22-26540274

  • Chairman

    Pradip P Shah

  • Managing Director

    Meenakshi Nevatia

  • Company Secretary

    Prajeet Nair

  • Auditor

    B S R & Co LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Pfizer Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Pfizer 4,259.45 2,373.68 2,193.17 31.66 21.43
Abbott India 30,094.35 6,097.18 5,848.91 47.92 44.71
Astrazeneca Phar 8,795.90 1,330.33 1,295.53 226.76 33.26
P & G Health Ltd 5,121.00 1,166.89 1,151.26 35.93 39.76
Glaxosmi. Pharma 2,904.45 3,530.73 3,407.25 57.75 44.44
Cipla 1,541.00 17,645.00 16,574.34 26.42 20.10
Amrutanjan Healt 679.10 437.58 421.23 39.81 20.84
Guj. Themis Bio. 285.15 174.19 169.82 59.04 44.82
Fermenta Biotec. 272.25 315.24 307.09 25.81 4.10
Bliss GVS Pharma 122.65 638.96 605.46 28.07 11.19
Ambalal Sarabhai 37.10 11.70 3.81 15.85 1.92